Open original FDA record ↗Recall record
- FDA identifier
- Z-0321-2021
- Company in FDA record
- Primus Corporation
- FDA record creation date
- Oct 31, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The product did not receive pre-market approval or clearance.
Source facts
- Action
- Recall letters have been sent to US consignees via Federal Express Priority Overnight delivery. Customers were advised to transition to alternate testing methods and qualify a replacement device by March 7, 2021. During the transition, consumables will be made available for use but must be destroyed upon return of the analyzer. Customers were also instructed to agree to the above requirements and return a Fax Back Form confirming compliance. Follow-up will be conducted with consignees that do not reply to the recall notification.
- Initiated
- 2020-10-09
- Root cause
- No Marketing Application
- Terminated
- 2021-11-04
- Distribution
- US - Arizona, California, District of Columbia, Florida, Georgia, Illinois, Louisiana, Massachusetts, Michigan, Missouri, Nebraska, New Jersey, Nevada, New York, Pennsylvania, Rhode Island, Tennessee, Texas, Virginia, Wisconsin OUS - Bahrain, Iran, Malaysia, Saudi Arabia, Taiwan, Turkey, UAE, UK, Vietnam
- Recall number
- Z-0321-2021
- Recall status
- Terminated
- CDRH record ID
- 184141
- FDA record created
- 2020-10-31
- Recall event number
- 86598